All Type of News
National health insurance to cover new rheumatism drug
The Ministry of Health and Welfare said Thursday that Janssen Korea’s rheumatism medication Simponi (golimumab) will be covered by national health insurance through the public hearing.
Simponi, the first once-month...
Government to support Chong Kun Dang’s dyslipidemia drug development
Chong Kun Dang Pharmaceutical said last Monday it has signed an agreement with the state-run Korea Drug Development Fund (KDDF).
The company plans to carry out clinical trials for its dyslipidemia drug candidate as...
Sales inch up but profits plummet at pharmaceutical firms
Korea's listed drug companies witnessed a sales inch up last year from a year earlier, but fell short of reaping more profits than the previous year, data showed Wednesday.
Sales by 50 listed firms rose 1.2 percent...
Saenuri Party’s committee member named health and welfare vice ministerPresident Park Geun-hye Wednesday named 20 vice ministers who are supposed to be specialists in their fields of expertise.
Park recruited Lee Young-chan, a health and welfar...
|
Small drug makers scramble to survive
Local drug manufacturers are seeking ways to compete abroad as their profits continue to fall in the domestic market after comprehensive price cuts of drugs by the government last April.
Smaller companies are also...
Daewoong releases Novosis, an innovative medical device
Daewoong Pharmaceutical said Tuesday it has launched Novosis, a new-concept medical device combining bone graft and rhBMP-2 (recombinant human bone morphogenetic protein-2).
Novosis is produced from recombinant E. ...
Chung named to head Janssen Korea’s legal affairsJanssen Korea said Wednesday it has appointed as its senior counsel, Chung Won-young, a female legal expert.
Chung will take charge of the company’s overall legal affairs.
...
|
Criteria on illegal kickbacks are dubious
The government joint team consisting of seven government organizations, including the Seoul Central District Prosecutors’ Office, Ministry of Health and Welfare, and National Police Agency, said Sunday it indicted 119...
Dong-A admits guilt over illegal rebates
Dong-A Pharmaceutical Co., the country’s biggest drug manufacturer, admitted during the first trial in the Seoul Central District Court on Tuesday that it was a kickback to give money to doctors in return for making e...
KFDA approves Erivedge for basal cell carcinoma
The Korea Food and Drug Administration said Tuesday that it approved Erivedge (vismodegib 150 mg) as a new treatment for adult patients with basal cell carcinoma, the most common type of skin cancer.
Developed by S...
